Navigation Links
Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Date:1/31/2008

SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York on Wednesday, February 6, 2008 at 1:00 p.m. ET / 10:00 a.m. PT. Mark G. Foletta, Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview.

The live presentation and breakout session will be webcast, and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate website, located at http://www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,900 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... hospitals with surgery validation using its Stratasys Objet24 and Objet30 ... surgery on 3D printed models prior to operations reduces theatre ... effective aid for both patient and surgeon   ... a global leader of 3D printing and additive manufacturing solutions, ...
(Date:8/26/2014)... AVENTURA. Fla. , Aug. 26, 2014 /PRNewswire/ ... trades under the symbol (NUUU) has two (2) ... Inc. Our two subsidiaries harness scientifically advanced technology ... NUUU,s Renuell Int,l, Inc. ... breakthrough anti-aging skin care products that is made ...
(Date:8/26/2014)... , Aug. 26, 2014 Trovagene, Inc. ... Generation Dx Summit; Moving Assays to the Clinic ... and Monitoring of Cell Free Tumor DNA in ... component of its Precision Cancer Monitoring (PCM) platform ... sensitivity for the detection of tumor DNA mutations ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... The Renewable Energy ... promising locations for renewable energy projects. ,The Atlas is the first tool of its kind ... select from a suite of renewable energy options including biomass, efficiency, geothermal, hydroelectric, solar and ... (PRWEB) ...
... ... Environmental Sustainability (EStar) award from the U.S. Department of Energy,s (DOE) Office of Science. ... Argonne, ... Gene/P supercomputer was recognized with an Environmental Sustainability (EStar) award from the U.S. Department ...
... ... of 2007 and to enhance patient safety with complete part traceability, can now use ... coding, scan and software tracking of each part and batch, including all leak test, ... ...
Cached Biology Technology:Vermont Launches Renewable Energy Atlas 2Vermont Launches Renewable Energy Atlas 3Vermont Launches Renewable Energy Atlas 4EStar Award Recognizes Innovative Supercomputer Cooling 2EStar Award Recognizes Innovative Supercomputer Cooling 3InterTech Development Company UDI System Announced 2
(Date:8/25/2014)... predominant strain of community-acquired methicillin-resistant Staphylococcus aureus ... East and northern Africa derived from a single ... this week in mBio , the online ... , CA-MRSA refers to MRSA infections occurring in ... which are typically skin infections, can be transmitted ...
(Date:8/25/2014)... deficiency is one of the most widespread causes of ... the United States are plagued by boron deficient soil ... supplement their soil with boron; however, little is known ... essential nutrient. Now, researchers at the University of Missouri ... development and reproduction in corn plants. Scientists anticipate that ...
(Date:8/25/2014)... that toxic effects of substances known as endocrine ... human-made materials, can pass from one generation to ... with ancestral exposure to EDC may show especially ... new study by researchers from The University of ... and female rats are affected differently by ancestral ...
Breaking Biology News(10 mins):Common European MRSA originated in Africa 2Researchers find boron facilitates stem cell growth and development in corn 2Exposure to toxins makes great granddaughters more susceptible to stress 2
... CITY People at risk for a certain form of ... better chance at surviving or even avoiding the diseases, thanks ... Institute at LDS Hospital. The Intermountain Heathcare group of ... cost-effective way to identify patients who may have Lynch syndrome, ...
... of researchers at the Department of Energy,s BioEnergy Science ... controls ethanol production capacity in a microorganism. This discovery ... that produce higher concentrations of ethanol at lower costs. ... the scientific discoveries of its labs and research centers ...
... study by an international team including professor John Graves of ... species of tunas and billfishes are threatened and in need ... issue of Science magazine,s Policy Forumis the first ... of the International Union for Conservation of Nature (IUCN). ,The ...
Cached Biology News:Study: New process that can save at-risk cancer patients is effective and significantly less costly 2Study: New process that can save at-risk cancer patients is effective and significantly less costly 3Single, key gene discovery could streamline production of biofuels 2Study helps assess global status of tuna and billfish stocks 2Study helps assess global status of tuna and billfish stocks 3